Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
135
+4
+3% +$365 ﹤0.01% 179
2026
Q1
$13K Buy
131
+25
+24% +$2.82K ﹤0.01% 174
2025
Q4
$13K Sell
106
-4
-4% -$510 ﹤0.01% 178
2025
Q3
$15K Sell
110
-4
-4% -$525 ﹤0.01% 180
2025
Q2
$16K Sell
114
-23
-17% -$3.03K ﹤0.01% 168
2025
Q1
$18K Buy
137
+105
+328% +$13.4K ﹤0.01% 162
2024
Q4
$4K Buy
+32
New +$3.7K ﹤0.01% 146

Other funds holding ABT

Clal Insurance's ABT Position: Q2 2026 in Review

Clal Insurance increased its Abbott (ABT) stake by 3.1% in Q2 2026, buying an estimated $365 and bringing the position to 135 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #179.

Clal Insurance first reported a position in ABT in Q4 2024 and has held it in 7 quarters since. The position peaked at $18K in Q1 2025. 2,965 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Clal Insurance held 135 shares of Abbott worth $12K as of Q2 2026.
  • Clal Insurance bought 4 Abbott shares in Q2 2026, an estimated $365.
  • Abbott made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #179 holding.
  • Clal Insurance first reported a position in Abbott in Q4 2024 and has held it in 7 quarters since.
  • Clal Insurance's Abbott position peaked at $18K in Q1 2025.
  • 2,965 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.